Health knowledge made personal
Join this community!
› Share page:
Search posts:

FDA Approved VYVANSE for the Treatment of ADHD in Adults

Posted Jun 04 2008 7:04pm

FDA Approves VYVANSE? (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults.

Within the first eight months since its introduction in the United States, VYVANSE has achieved over one million prescriptions.

In a clinical study with adults, VYVANSE was shown to significantly improve the symptoms of ADHD (inattention, hyperactivity and impulsivity).

"We are very pleased with this FDA approval of the adult indication for VYVANSE," said Matthew Emmens, Chief Executive Officer of Shire. "This approval provides physicians a new treatment option that can help their adult patients by significantly improving their ADHD symptoms. VYVANSE has been well accepted by the medical community. With Shire's experience as a leader in the development and commercialization of ADHD medications, we are confident that this approval for adult patients will help continue to increase prescription share and volume of VYVANSE."

"Many people may think of ADHD as only a childhood disorder but the fact is that the majority of children diagnosed with ADHD still have symptoms as an adult. These symptoms can significantly impact them at work, home and in relationships, where they have important responsibilities," said David W. Goodman, assistant professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine and director of the Adult Attention Deficit Disorder Center of Maryland. "The good news is that in a clinical study with adults, one daily dose of VYVANSE significantly improved ADHD symptoms of inattention, such as the ability to focus and organize, as well as hyperactivity and impulsivity."

Talk to your doctor to see if this drug might be right for you.

Dr. Dominic Gaziano - Dr. G
The Feel Good Health Guy / Health & Wellness Expert

Post a comment
Write a comment:

Related Searches